VivoSeq
Other

Cystic

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Cystic is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

14/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed2 · 29%
Not yet recruiting2 · 29%
Unknown status2 · 29%
Terminated1 · 14%

Clinical Trials

Trial Activity

7 trials

Microbiome and Polycystic Ovaries
Not yet recruiting·SSheba Medical Center·N/A·NCT04836910·40 enrolled
Cardiometabolic Health in Women With Overweight or Obesity, With or Without Polycystic Ovary Syndrome: Effects of a Targeted Adapted Physical Activity Program
Not yet recruiting·UUniversity Hospital, Clermont-Ferrand·Preclinical·NCT07659392·40 enrolled
Everolimus and LongActing Octreotide Trial in Polycystic Livers
Completed·RRadboud University Medical Center·Phase 2·NCT01157858·44 enrolled
Study of Two Dosages of Roaccutane in Cystic Acne
Completed·—·Phase 4·NCT07228481·91 enrolled
Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
Terminated·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·Phase 4·NCT02785822·19 enrolled
Sirolimus for Massive Polycystic Liver
Unknown status·SSeoul National University Hospital·Phase 2/3·NCT01680250·44 enrolled
Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
Unknown status·—·Phase 4·NCT04094467·150 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)